A population-based case-control study of canine mammary tumours and clinical use of medroxyprogesterone acetate

APMIS

Volumn 105, Issue 8, 1997, Pages 590-596

  StØvring, Merete ^a   Moe, Lars ^a   Glattre, Eystein ^a,b  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

Dog; Mammary tumour; Medroxyprogesterone acetate; Progestins

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DOG; FEMALE; HORMONE SUBSTITUTION; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TOXICITY TESTING;

EID: 0030760948     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1997.tb05057.x     Document Type: Article

References (37)

1. Arnesen, K., Gamlem, H., Glattre, E., Moe, L. & Nordstoga, K.: Registrering av kreft hos hund. (Cancer registration in dogs.) Tidsskr. Nor. Lægeforen. 115: 714-717, 1995.
2. Briggs, M.: The beagle dog and contraceptive steroids. Life Sci. 21: 275-284, 1977.
3. Brodey, R. S., Goldschmidt, M. H. & Roszel, J. R.: Canine mammary gland neoplasms. J. Am. Anim. Hosp. Assoc. 19: 61-90, 1983.
4. Bryan, H. S.: Parenteral use of medroxyprogesterone acetate as an antifertility agent in the bitch. Am. J. Vet. Res. 34: 659-663, 1973.
5. Cameron, A. M. & Faulkin, L. J., Jr.: Hyperplastic and inflammatory nodules in the canine mammary gland. J. Natl. Cancer Inst. 47: 1277-1287, 1971.
6. Chilvers, C.: Oral contraceptives and cancer [commentary]. Lancet 344: 1378-1379, 1994.
7. Concannon, P., Altszuler, N., Hampshire, J., Butler, W. R. & Hansel, W.: Growth hormone, prolactin, and cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate. Endocrinology 106: 1173-1177, 1980.
8. Concannon, P. W., Spraker, T. R., Casey, H. W. & Hansel, W.: Gross and histopathologic effects of medroxyprogesterone acetate and progesterone on the mammary glands of adult beagle bitches. Fertil. Steril. 36: 373-387, 1981.
9. Dean, A. G., Dean, J. A., Burton, A. H. & Dicker, R. C.: Epi Info, Version 5: a word processing, database, and statistics program for epidemiology on microcomputers. USD, 1990 Inc: Stone Mountain, Georgia.
10. Eigenmann, J. E. & Eigenmann, R. Y.: Influence of medroxyprogesterone acetate (Provera) on plasma growth hormone levels and on carbohydrate metabolism. II. Studies in the ovariohysterectomized, oestradiol-primed bitch. Acta Endocrinol. (Copenh.) 98: 603-608, 1981.
11. Eigenmann, J. E. & Rijnberk, A.: Influence of medroxyprogesterone acetate (Provera) on plasma growth hormone levels and on carbohydrate metabolism. I. Studies in the ovariohysterectomized bitch. Acta Endocrinol. (Copenh.) 98: 599-602, 1981.
12. El Etreby, M. F. & Gräf, K.-J.: Effect of contraceptive steroids on mammary gland of beagle dog and its relevance to human carcinogenicity. Pharmacol. Ther. 5: 369-402, 1979.
13. El Etreby, M. F., Graf, K.-J., Beier, S., Elger, W., Günzel, P. & Neumann, F.: Suitability of the beagle dog as a test model for the tumorigenic potential of contraceptive steroids "A short review". Contraception 20: 237-256, 1979.
14. Ferguson, H. R.: Canine mammary gland tumors. Vet. Clin. North Am. Small Anim. Pract. 75: 501-511, 1985.
15. Fowler, E. H., Vaughan, T., Gotscik, F., Reichhart, P. & Reed, C.: Pathologic changes in mammary glands and uteri from beagle bitches receiving low levels of medroxyprogesterone acetate: an overview of research in progress. In: Garattini, S. & Berendes, H. W. (Eds.): Pharmacology of Steroid Contraceptive Drugs. Raven Press, New York 1977, pp. 185-210.
16. Frank, D. W., Kirton, K. T., Murchison, T. E., Quinlan, W. J., Coleman, M. E., Gilbertson, T. J., Feenstra, E. S. & Kimball, F. A.: Mammary tumors and serum hormones in the bitch treated with medroxyprogesterone acetate or progesterone for four years. Fertil. Steril. 31: 340-346, 1979.
17. Geil, R. G. & Lamar, J. K.: FDA studies of oestrogen, progestogen, and oestrogen/progestogen combinations in the dog and monkey. J. Toxicol. Environ. Health 3: 179-193, 1977.
18. Hamilton, J. M.: A review of recent advances in the study of the aetiology of canine mammary tumours. Vet. Annu. 15: 276-283, 1975.
19. Hampe, J. F. & Misdorp, W.: IX. Tumours and dysplasias of the mammary gland. Bull. World Health Organ. 50: 111-133, 1974.
20. Hansel, W., Concannon, P. W. & McEntee, K.: Plasma hormone profiles and pathological observations in medroxyprogesterone acetate-treated beagle bitches. In: Garattini, S. & Berendes, H. W. (Eds.): Pharmacology of Steroid Contraceptive Drugs. Raven Press, New York 1977, pp. 145-161.
21. Karayannopoulou, M., Kaldrimidou, E. & Dessiris, A.: Some epidemiological aspects of canine mammary tumours, treatment and prognosis. Eur. J. Companion Anim. Pract. 1: 41-47, 1990.
22. Koch, H.: 10 years' retrospective observation on the use of medroxyprogesterone acetate in small animals [translated reprint Kleintierpraxis 4: 185-186, 1989], M. & H. Schaper: Alfeld (Leine). Germany.
23. Kwapien, R. P., Giles, R. C., Geil, R. G. & Casey, H. W.: Malignant mammary tumors in beagle dogs dosed with investigational oral contraceptive steroids. J. Natl. Cancer Inst. 65: 137-144, 1980.
24. Misdorp, W.: Canine mammary tumours: protective effect of late ovariectomy and stimulating effect of progestins. Vet. Q. 10: 26-33, 1988.
25. Misdorp, W.: Progestagens and mammary tumours in dogs and cats. Acta Endocrinol. (Copenh.) 125 (Suppl. 1): 27-31, 1991.
26. Moulton, J. E.: Tumors of the mammary gland. In: Moulton, J. E. (Ed.): Tumors in Domestic Animals, 3rd ed. University of California Press, California 1990, pp. 518-552.
27. Ockens, N.: Anvendelse af medroxyprogesteronacetat (Perlutex®) i danske smådyrsklinikker. (Use of medroxyprogesterone acetate (Perlutex®) in Danish small animals clinics) Dan. Vet. Tidsskr. 66: 888-893, 1983.
28. Rookus, M. A. & Van Leeuwen, F. E.: Oral contraceptives and risk of breast cancer in women aged 20-35 years. Lancet 344: 844-851, 1994.
29. Rutteman, G. R.: Contraceptive steroids and the mammary gland: is there a hazard? - Insights from animal studies. Breast Cancer Res. Treat. 23: 29-41, 1992.
30. Schneider, R., Dorn, R. C. & Taylor, D. O. N.: Factors influencing canine mammary cancer development and postsurgical survival. J. Natl. Cancer Inst. 43: 1249-1261, 1969.
31. Selman, P. J., Mol, J. A., Rutteman, G. R. & Rijnberk, A.: Progestins and growth hormone excess in the dog. Acta Endocrinol. (Copenh.) 125 (Suppl. 1): 42-47, 1991.
32. Selman, P. J., Mol, J. A., Rutteman, G. R., van Garderen, E. & Rijnberk, A.: Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 134: 287-292, 1994.
33. Sonnenschein, E. G., Glickman, L. T., Goldschmidt, M. H. & McKee, L. J.: Body conformation, diet, and risk of breast cancer in pet dogs: a case-control study. Am. J. Epidemiol. 133: 694-703, 1991.
34. Staffa, J. A., Newschaffer, C. J., Jones, J. K. & Miller, V.: Progestins and breast cancer: an epidemiologic review. Fertil. Steril. 57: 473-491, 1992.
35. Van Leeuwen, F. E.: Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer. Acta Endocrinol. (Copenh.) 125 (Suppl. 1): 13-26, 1991.
36. Van Os, J. L., Van Laar, P. H., Oldenkamp, E. P. & Verschoor, J. S. C.: Oestrus control and the incidence of mammary nodules in bitches, a clinical study with two progestogens. Vet. Q. 3: 46-56, 1981.
37. Warner, M. R.: Age incidence and site distribution of mammary dysplasias in young beagle bitches. J. Natl. Cancer Inst. 57: 57-61, 1976.